Editorial Policy

01 — Gathering

Items are gathered automatically from public news outlets, press releases, regulatory notices, clinical trial registries and scientific publications.

02 — Summarizing

Each item is summarized by AI tools. Summaries describe what is being reported and claimed; we do not verify safety or efficacy.

03 — Human approval

Nothing is published until a human editor reviews and approves it.

04 — Sourcing

Every item links to its original source. Where a summary and its source disagree, the source governs.

05 — Opinion

Editorial opinion appears only in sections clearly labeled as such, including "Our Take", "Hype vs. Evidence" and "Momentum".

06 — Methodology: Evidence vs. Hype

Each peptide carries two editorial ratings from 1 to 5. Evidence reflects the strength of published human data, from anecdote (1) to large randomized trials for an approved use (5). Hype reflects how loudly the compound is promoted in media, marketing and online communities. These are editorial judgments, not scientific scores, and are reviewed when new data appears. Momentum describes recent news flow.

07 — Corrections

Spotted an error? Send a correction through the contact page.

08 — Independence

We are not a store, carry no affiliate links and are not affiliated with any peptide seller. We never publish dosing, protocols or where to buy.